Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-09-19FDA Approved: DOCETAXEL — Supplemental Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal's supplemental application to manufacture and market a generic docetaxel, enabling its supply for cancer treatment i…
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Tislelizumab Combined With Nab-paclitaxel and Gemcitabine for Recurrent Pancreatic Cancer [Phase 2]
Phase 2 trial updating tislelizumab with nab-paclitaxel and gemcitabine for recurrent pancreatic cancer is being investigated.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 [Phase 2]
Phase 2 clinical trial update for borderline resectable pancreatic cancer focusing on neoadjuvant chemoradiotherapy.
-
CLINICAL_TRIALS trial_result · 2023-09-01Clinical Trial Update: Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating an immunotherapy combined with chemotherapy for locally advanced and metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-08-30Clinical Trial Update: SBRT Plus vNKT for Pancreatic Cancer [Phase 2]
A Phase 2 clinical trial evaluating SBRT plus vNKT therapy for pancreatic cancer is ongoing, with status currently unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy [Phase 2]
Phase 2 trial of adjuvant gemcitabine and capecitabine chemotherapy after neoadjuvant therapy in resected pancreatic cancer is updating its …
-
CLINICAL_TRIALS trial_result · 2023-08-15Clinical Trial Update: Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for CBP501/Cisplatin/Nivolumab in advanced pancreatic cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refractory Pancreatic Cancer [Phase 3]
Phase 3 trial update comparing irinotecan liposome plus 5-FU/LV versus 5-FU/LV alone as second-line therapy in gemcitabine-refractory pancre…
-
CLINICAL_TRIALS trial_result · 2023-08-04Clinical Trial Update: AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating AZD0530 with gemcitabine in locally advanced or metastatic pancreatic cancer that is unresectable.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene [Phase 1, Phase 2]
Phase 1/2 clinical trial studying A166 in patients with various HER2-expressing or HER2-amplified cancers has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-01Clinical Trial Update: TAA Specific Cytotoxic T Lymphocytes in Patients With Pancreatic Cancer [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating tumor-associated antigen-specific cytotoxic T lymphocytes in pancreatic cancer has completed. Results we…
-
CLINICAL_TRIALS trial_result · 2023-07-25Clinical Trial Update: Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update for advanced pancreatic cancer with progression-free survival as a listed condition.
-
CLINICAL_TRIALS trial_result · 2023-07-13Clinical Trial Update: A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) [Phase 1, Phase 2]
Clinical trial update for KVA12123 as a standalone and in combination with pembrolizumab in advanced solid tumors; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers [Phase 2]
Phase 2 clinical trial evaluating nivolumab with tadalafil and oral vancomycin in patients with refractory hepatocellular carcinoma or liver…
-
CLINICAL_TRIALS trial_result · 2023-07-10Clinical Trial Update: Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer [Phase 2]
Phase 2 trial update on combining CRS-207 with nivolumab and ipilimumab, with or without GVAX pancreas vaccine, in pancreatic cancer; the st…
-
CLINICAL_TRIALS trial_result · 2023-07-05Clinical Trial Update: Azacitidine and Pembrolizumab in Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating azacitidine in combination with pembrolizumab in pancreatic cancer has completed with results posted in July 2023.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Niraparib + Dostarlimab + RT in Pancreatic Cancer [Phase 2]
Phase 2 trial results of Niraparib plus Dostarlimab with radiotherapy in pancreatic cancer have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2023-07-03Clinical Trial Update: Efficacy of Doxycycline on Metakaryote Cell Death in Patients With Resectable Pancreatic Cancer [Phase 2]
Phase 2 clinical trial assessing doxycycline for metakaryote cell death in patients with resectable pancreatic cancer; study completed with …
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Safety and Efficacy of FalateScan (Technetium Tc 99m EC20) in Patients With Known Suspected Recurrent or Metastatic Cancer From a Solid Tumor [Phase 2]
Phase 2 clinical trial evaluating FalateScan (Technetium Tc 99m EC20) for safety and efficacy in patients with suspected recurrent or metast…
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update investigating the combination of Anlotinib with an Anti-PD-1 antibody (AK105) for advanced pancreatic cancer across Ph…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Neoadjuvant Plus Adjuvant or Only Adjuvant Nab- Paclitaxel Plus Gemcitabine for Resectable Pancreatic Cancer [Phase 2]
Phase 2 trial evaluating neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine in resectable pancreatic cancer has comp…
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating chemotherapy and radiation therapy for locally advanced pancreatic cancer has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas [Phase 2]
Phase 2 clinical trial update on combination chemotherapy for locally advanced or metastatic pancreatic cancer.
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation [Phase 2]
Phase 2 trial evaluating rucaparib in pancreatic cancer patients with a deleterious BRCA mutation has completed.
-
CLINICAL_TRIALS trial_result · 2023-06-09Clinical Trial Update: Clinical Outcomes for Offering Genetic Testing in a Tiered Approach [NA]
A completed clinical trial evaluating the outcomes of offering genetic testing in a tiered approach, with results posted in 2023.